Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Discovery of Metabolic Biomarkers Predicting Radiation Therapy Late Effects in Prostate Cancer Patients.

Cheema AK, Grindrod S, Zhong X, Jain S, Menon SS, Mehta KY, Suy S, Collins S, Wang Y, Timofeeva O, Bandi G, Pahira J, Kowalczyk K, Lynch J, Dritschilo A.

Adv Exp Med Biol. 2019;1164:141-150. doi: 10.1007/978-3-030-22254-3_11.

PMID:
31576546
2.

Aminopeptidase P Mediated Targeting for Breast Tissue Specific Conjugate Delivery.

Cordova A, Woodrick J, Grindrod S, Zhang L, Saygideger-Kont Y, Wang K, DeVito S, Daniele SG, Paige M, Brown ML.

Bioconjug Chem. 2016 Sep 21;27(9):1981-90. doi: 10.1021/acs.bioconjchem.5b00481. Epub 2016 Aug 19.

3.

Small-molecule "BRCA1-mimetics" are antagonists of estrogen receptor-α.

Ma Y, Tomita Y, Preet A, Clarke R, Englund E, Grindrod S, Nathan S, De Oliveira E, Brown ML, Rosen EM.

Mol Endocrinol. 2014 Dec;28(12):1971-86. doi: 10.1210/me.2014-1146.

4.

Novel carbazole inhibits phospho-STAT3 through induction of protein-tyrosine phosphatase PTPN6.

Hou S, Yi YW, Kang HJ, Zhang L, Kim HJ, Kong Y, Liu Y, Wang K, Kong HS, Grindrod S, Bae I, Brown ML.

J Med Chem. 2014 Aug 14;57(15):6342-53. doi: 10.1021/jm4018042. Epub 2014 Aug 4.

5.

Synthesis and biological evaluation of a fluorescent analog of phenytoin as a potential inhibitor of neuropathic pain and imaging agent.

Walls TH, Grindrod SC, Beraud D, Zhang L, Baheti AR, Dakshanamurthy S, Patel MK, Brown ML, MacArthur LH.

Bioorg Med Chem. 2012 Sep 1;20(17):5269-76. doi: 10.1016/j.bmc.2012.06.042. Epub 2012 Jul 3.

6.

Histone deacetylase cytoplasmic trapping by a novel fluorescent HDAC inhibitor.

Kong Y, Jung M, Wang K, Grindrod S, Velena A, Lee SA, Dakshanamurthy S, Yang Y, Miessau M, Zheng C, Dritschilo A, Brown ML.

Mol Cancer Ther. 2011 Sep;10(9):1591-9. doi: 10.1158/1535-7163.MCT-10-0779. Epub 2011 Jun 22.

7.

Fluorescent cyclin-dependent kinase inhibitors block the proliferation of human breast cancer cells.

Yenugonda VM, Deb TB, Grindrod SC, Dakshanamurthy S, Yang Y, Paige M, Brown ML.

Bioorg Med Chem. 2011 Apr 15;19(8):2714-25. doi: 10.1016/j.bmc.2011.02.052. Epub 2011 Mar 4.

PMID:
21440449
8.

Effects of a fluorescent Myosin light chain phosphatase inhibitor on prostate cancer cells.

Grindrod S, Suy S, Fallen S, Eto M, Toretsky J, Brown ML.

Front Oncol. 2011 Sep 20;1:27. doi: 10.3389/fonc.2011.00027. eCollection 2011.

9.

VMY-1-103, a dansylated analog of purvalanol B, induces caspase-3-dependent apoptosis in LNCaP prostate cancer cells.

Ringer L, Sirajuddin P, Yenugonda VM, Ghosh A, Divito K, Trabosh V, Patel Y, Brophy A, Grindrod S, Lisanti MP, Rosenthal D, Brown ML, Avantaggiati ML, Rodriguez O, Albanese C.

Cancer Biol Ther. 2010 Aug 15;10(4):320-5. Epub 2010 Aug 3.

10.

Fluorescent epigenetic small molecule induces expression of the tumor suppressor ras-association domain family 1A and inhibits human prostate xenograft.

Sheikh KD, Banerjee PP, Jagadeesh S, Grindrod SC, Zhang L, Paige M, Brown ML.

J Med Chem. 2010 Mar 25;53(6):2376-82. doi: 10.1021/jm9011615.

PMID:
20184324
11.

Synthesis of C-glycoside analogues of beta-galactosamine-(1-->4)-3-O-methyl-D-chiro-inositol and assay as activator of protein phosphatases PDHP and PP2Calpha.

Hans SK, Camara F, Altiti A, Martín-Montalvo A, Brautigan DL, Heimark D, Larner J, Grindrod S, Brown ML, Mootoo DR.

Bioorg Med Chem. 2010 Feb;18(3):1103-10. doi: 10.1016/j.bmc.2009.12.056. Epub 2010 Jan 4.

12.

Asymmetric synthesis of 2,3-dihydro-2-arylquinazolin-4-ones: methodology and application to a potent fluorescent tubulin inhibitor with anticancer activity.

Chinigo GM, Paige M, Grindrod S, Hamel E, Dakshanamurthy S, Chruszcz M, Minor W, Brown ML.

J Med Chem. 2008 Aug 14;51(15):4620-31. doi: 10.1021/jm800271c. Epub 2008 Jul 9.

13.

Allosteric activation of protein phosphatase 2C by D-chiro-inositol-galactosamine, a putative mediator mimetic of insulin action.

Brautigan DL, Brown M, Grindrod S, Chinigo G, Kruszewski A, Lukasik SM, Bushweller JH, Horal M, Keller S, Tamura S, Heimark DB, Price J, Larner AN, Larner J.

Biochemistry. 2005 Aug 23;44(33):11067-73. Erratum in: Biochemistry. 2005 Nov 22;44(46):15422.

PMID:
16101290
14.
15.
16.

Three-dimensional visualization of data on human anatomy: diagnosis and surgical planning.

Linney AD, Tan AC, Richards R, Gardener J, Grindrod S, Moss JP.

J Audiov Media Med. 1993 Jan;16(1):4-10.

PMID:
8370913
17.

Using greyscale voxel databases for improved shading and segmentation.

Arridge SR, Grindrod SR, Linney AD, Tofts PS, Wicks D.

Med Inform (Lond). 1989 Apr-Jun;14(2):157-71. Erratum in: Med Inf (Lond) 1989 Oct-Dec;14(4):267.

PMID:
2755270
18.

Three-dimensional visualization of computerized tomography and laser scan data for the simulation of maxillo-facial surgery.

Linney AD, Grindrod SR, Arridge SR, Moss JP.

Med Inform (Lond). 1989 Apr-Jun;14(2):109-21.

PMID:
2755266
19.

A computer system for the interactive planning and prediction of maxillofacial surgery.

Moss JP, Grindrod SR, Linney AD, Arridge SR, James D.

Am J Orthod Dentofacial Orthop. 1988 Dec;94(6):469-75.

PMID:
3195511
20.

Three-dimensional visualization of the face and skull using computerized tomography and laser scanning techniques.

Moss JP, Linney AD, Grindrod SR, Arridge SR, Clifton JS.

Eur J Orthod. 1987 Nov;9(4):247-53. No abstract available.

PMID:
3480225
21.

Investigation of human skeletal muscle structure and composition by X-ray computerised tomography.

Grindrod S, Tofts P, Edwards R.

Eur J Clin Invest. 1983 Dec;13(6):465-8.

PMID:
6416864
22.

The potential resolution of a 137Cs computerized tomographic scanner for radiotherapy planning.

Grindrod SR.

Br J Radiol. 1979 Apr;52(616):322-4. No abstract available.

PMID:
444824

Supplemental Content

Loading ...
Support Center